Specialty Pharmacy

The CRISPR system may revolutionize the treatment of a range of diseases.

An antibody showed the ability to bind to the protein Bak and cause apoptosis.

New drug class offers hope for lymphomas and leukemia.

Blocking the ERK1/2 pathway and the compensatory ERK5 pathway stopped the growth of colorectal tumors.

The Right to Try Act allows terminally ill patients to take investigational treatments that have passed basic safety testing.

Improving the function neuron activity may effectively treat Rett syndrome.

Volanesorsen improved insulin sensitivity and glucose control in type 2 diabetes.

Top news of the day from across the health care landscape.

Sandoz to create biosimilars for 5 popular branded drugs.

Liver cancer cells died when the AURKA-MYC interaction was inhibited.

Deficient copies of gene leaves some patients more susceptible for melanoma.

Antiretroviral therapy use and viral suppression heavily impacted by issues such as poverty and race.

Ixekizumab fully or partially cleared moderate-to-severe psoriasis in 80% of patients.

Dimethylfumarate could provide a new treatment option for several neurodegenerative diseases.

Mindfulness-based treatments may benefit patients with type 2 diabetes.

An antibody derived from the human immune system may kill cancer cells with less harm to patient.

Top news of the day from across the health care landscape.

Previous research has supported coffee consumption for reducing the risk of diseases such as cancer.

Novel agents using dill and parsley extracts show promise fighting cancer.

Ocrevus is an investigational, humanized monoclonal antibody that selectively targets CD20-positive B cells in multiple sclerosis.

Epclusa showed up to 99% viral suppression after 12 weeks across major hepatitis C genotypes.

Presence of different antibodies in the blood can influence response to abatacept regimen.

More work is need to determine the impact of weight loss programs in lowering blood sugar concentrations in type 2 diabetes.

Targeting cancer-driving proteins may further efforts in personalized cancer medication research.

Design of formulations based on flavopiridol shows promise inhibiting brain cancer cell growth.

Top news of the day from across the health care landscape.

Some injection drug users with HIV and hepatitis C seem to have the same immune problems as the elderly.

Study suggests an approximately 2.5-year survival increase compared with placebo or no maintenance in patients with multiple myeloma.